Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)

Organogenesis Holdings has reported Non-Current Deffered Revenue over the past 5 years, most recently at $1.1 million for Q3 2020.

  • For Q3 2020, Non-Current Deffered Revenue rose 49.18% year-over-year to $1.1 million; the TTM value through Sep 2020 reached $1.1 million, up 49.18%, while the annual FY2019 figure was $1.0 million, 678.46% up from the prior year.
  • Non-Current Deffered Revenue for Q3 2020 was $1.1 million at Organogenesis Holdings, roughly flat from $1.1 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $10.8 million in Q4 2016 and troughed at $74000.0 in Q4 2017.
  • A 5-year average of $4.8 million and a median of $1.1 million in 2020 define the central range for Non-Current Deffered Revenue.
  • Biggest five-year swings in Non-Current Deffered Revenue: crashed 99.32% in 2017 and later soared 678.46% in 2019.
  • Year by year, Non-Current Deffered Revenue stood at $10.8 million in 2016, then crashed by 99.32% to $74000.0 in 2017, then skyrocketed by 75.68% to $130000.0 in 2018, then soared by 678.46% to $1.0 million in 2019, then grew by 8.5% to $1.1 million in 2020.
  • Business Quant data shows Non-Current Deffered Revenue for ORGO at $1.1 million in Q3 2020, $1.1 million in Q2 2020, and $1.1 million in Q1 2020.